Analyst Price Targets — BLFS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| January 5, 2026 2:17 pm | — | Northland Securities | $34.00 | $25.14 | TheFly | BioLife Solutions price target raised, named a 2026 Top Pick at Northland |
| November 24, 2025 11:40 am | Yi Chen | H.C. Wainwright | $32.00 | $26.53 | StreetInsider | H.C. Wainwright Reiterates Buy Rating on BioLife Solutions (BLFS) |
| March 5, 2025 5:11 pm | — | H.C. Wainwright | $30.00 | $26.25 | TheFly | BioLife Solutions price target raised to $30 from $27 at H.C. Wainwright |
| November 15, 2024 12:14 pm | Jacob Johnson | Stephens | $30.00 | $21.58 | StreetInsider | Stephens Reiterates Overweight Rating on BioLife Solutions (BLFS) |
| August 12, 2024 8:39 am | Matt Hewitt | Craig-Hallum | $30.00 | $25.25 | TheFly | BioLife Solutions price target raised to $30 from $23 at Craig-Hallum |
| April 4, 2024 2:41 am | Matthew Stanton | Jefferies | $22.00 | $17.32 | StreetInsider | Jefferies Starts BioLife Solutions (BLFS) at Buy, 'Getting Back to Basics, Cleaner Story Post Pending Freezer Divestiture' |
Latest News for BLFS
The mean of analysts' price targets for BioLife Solutions (BLFS) points to a 35% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
BioLife Solutions, Inc. (NASDAQ: BLFS - Get Free Report)'s stock price gapped up before the market opened on Friday. The stock had previously closed at $22.48, but opened at $23.50. BioLife Solutions shares last traded at $25.01, with a volume of 191,296 shares changing hands. More BioLife Solutions News Here are the key news stories
BioLife Solutions, Inc. (BLFS) Q4 2025 Earnings Call Transcript
BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to a loss of $0.01 per share a year ago.
Fourth quarter 2025 revenue from continuing operations of $24.8 million, up 20% year-over-year; Full year 2025 revenue of $96.2 million, up 29% year-over-year GAAP gross margin of 63% and non-GAAP adjusted gross margin of 64% for the fourth quarter GAAP net income of $2.1 million or $0.04 per share and adjusted EBITDA of $6.9 million, or 28% of total revenue for the fourth quarter Expects 2026 revenue growth of…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for BLFS.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.